RegentAtlantic Capital’s Stryker SYK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $5.94M | Buy |
29,341
+920
| +3% | +$194K | 0.18% | 90 |
|
|
2022
Q2 | $5.65M | Buy |
28,421
+764
| +3% | +$179K | 0.19% | 96 |
|
|
2022
Q1 | $7.39M | Buy |
27,657
+3,569
| +15% | +$924K | 0.21% | 84 |
|
|
2021
Q4 | $6.44M | Buy |
24,088
+677
| +3% | +$178K | 0.18% | 95 |
|
|
2021
Q3 | $6.17M | Buy |
23,411
+913
| +4% | +$244K | 0.19% | 93 |
|
|
2021
Q2 | $5.84M | Buy |
22,498
+1,702
| +8% | +$435K | 0.18% | 97 |
|
|
2021
Q1 | $5.07M | Buy |
20,796
+1,060
| +5% | +$254K | 0.17% | 104 |
|
|
2020
Q4 | $4.84M | Buy |
19,736
+798
| +4% | +$181K | 0.19% | 98 |
|
|
2020
Q3 | $3.95M | Sell |
18,938
-111
| -0.6% | -$21.6K | 0.18% | 106 |
|
|
2020
Q2 | $3.43M | Buy |
19,049
+583
| +3% | +$108K | 0.19% | 103 |
|
|
2020
Q1 | $3.07M | Sell |
18,466
-83
| -0.4% | -$16.2K | 0.24% | 101 |
|
|
2019
Q4 | $3.89M | Sell |
18,549
-142
| -0.8% | -$29.5K | 0.24% | 110 |
|
|
2019
Q3 | $4.04M | Sell |
18,691
-510
| -3% | -$109K | 0.27% | 99 |
|
|
2019
Q2 | $3.95M | Sell |
19,201
-48
| -0.2% | -$9.17K | 0.27% | 97 |
|
|
2019
Q1 | $3.8M | Sell |
19,249
-423
| -2% | -$76.1K | 0.26% | 95 |
|
|
2018
Q4 | $3.08M | Sell |
19,672
-540
| -3% | -$90.3K | 0.26% | 103 |
|
|
2018
Q3 | $3.59M | Sell |
20,212
-100
| -0.5% | -$17.1K | 0.28% | 97 |
|
|
2018
Q2 | $3.43M | Sell |
20,312
-170
| -0.8% | -$28.6K | 0.3% | 93 |
|
|
2018
Q1 | $3.3M | Sell |
20,482
-374
| -2% | -$60.3K | 0.28% | 102 |
|
|
2017
Q4 | $3.23M | Sell |
20,856
-525
| -2% | -$80.1K | 0.26% | 104 |
|
|
2017
Q3 | $3.04M | Sell |
21,381
-102
| -0.5% | -$14.6K | 0.26% | 108 |
|
|
2017
Q2 | $2.98M | Sell |
21,483
-31
| -0.1% | -$4.25K | 0.27% | 105 |
|
|
2017
Q1 | $2.83M | Sell |
21,514
-211
| -1% | -$26.7K | 0.26% | 107 |
|
|
2016
Q4 | $2.6M | Sell |
21,725
-121
| -0.6% | -$13.9K | 0.25% | 108 |
|
|
2016
Q3 | $2.54M | Sell |
21,846
-65
| -0.3% | -$7.57K | 0.26% | 103 |
|
|
2016
Q2 | $2.63M | Sell |
21,911
-1,200
| -5% | -$134K | 0.25% | 99 |
|
|
2016
Q1 | $2.48M | Sell |
23,111
-475
| -2% | -$46.8K | 0.27% | 95 |
|
|
2015
Q4 | $2.19M | Sell |
23,586
-461
| -2% | -$44.1K | 0.23% | 117 |
|
|
2015
Q3 | $2.26M | Sell |
24,047
-295
| -1% | -$29.2K | 0.22% | 117 |
|
|
2015
Q2 | $2.33M | Sell |
24,342
-538
| -2% | -$51K | 0.21% | 117 |
|
|
2015
Q1 | $2.29M | Sell |
24,880
-845
| -3% | -$78.7K | 0.2% | 120 |
|
|
2014
Q4 | $2.43M | Sell |
25,725
-1,440
| -5% | -$128K | 0.21% | 115 |
|
|
2014
Q3 | $2.19M | Sell |
27,165
-1,042
| -4% | -$85.7K | 0.21% | 119 |
|
|
2014
Q2 | $2.38M | Buy |
28,207
+825
| +3% | +$67.4K | 0.22% | 105 |
|
|
2014
Q1 | $2.23M | Sell |
27,382
-1,669
| -6% | -$133K | 0.22% | 108 |
|
|
2013
Q4 | $2.18M | Sell |
29,051
-670
| -2% | -$48.9K | 0.21% | 117 |
|
|
2013
Q3 | $2.01M | Sell |
29,721
-45
| -0.2% | -$3.11K | 0.22% | 116 |
|
|
2013
Q2 | $1.93M | Buy |
+29,766
| New | +$1.98M | 0.23% | 114 |
|
Other funds holding SYK
GT
RegentAtlantic Capital's SYK Position: Q3 2022 in Review
RegentAtlantic Capital increased its Stryker (SYK) stake by 3.2% in Q3 2022, buying an estimated $194K and bringing the position to 29,341 shares worth $5.94M. The position accounts for 0.18% of the portfolio, ranked #90.
RegentAtlantic Capital first reported a position in SYK in Q2 2013 and has held it in 38 quarters since. The position peaked at $7.39M in Q1 2022. 1,531 funds tracked by Wall St. Rank hold SYK as of Q3 2022.
- RegentAtlantic Capital held 29,341 shares of Stryker worth $5.94M as of Q3 2022.
- RegentAtlantic Capital bought 920 Stryker shares in Q3 2022, an estimated $194K.
- Stryker made up 0.18% of RegentAtlantic Capital's portfolio in Q3 2022, its #90 holding.
- RegentAtlantic Capital first reported a position in Stryker in Q2 2013 and has held it in 38 quarters since.
- RegentAtlantic Capital's Stryker position peaked at $7.39M in Q1 2022.
- 1,531 funds tracked by Wall St. Rank held Stryker as of Q3 2022.
Based on RegentAtlantic Capital's 13F filing for Q3 2022, filed 14 Nov 2022.